Stänger fas II-studie Guard meddelade i fredags att de valt att avsluta rekryteringen till den påg...
Justerar kvartalsestimat Vi har gått igenom våra estimat och valt att göra vissa justeringar på kv...
Medivir has presented positive pre-clinical results with fostrox in a triple combination at the AACR...
Redeye states its view on Hoylu’s Q1 2023 report, announced earlier today.
Redeye increases its Arise estimates and fair value range following the acquisition of Pohjan Voima.
Fiskars' H1 2023 is likely to be challenging, with both its own and its customers' inventories being...
Q1e: SEK 190m sales, +4.7% y-o-y; 6.5m EBITA, 3.4% margin Minor estimate changes; reiterate fair val...
According an article by the Wall Street Journal on Friday night 14 April, Japanese gaming company Se...
Zoomability Int AB meddelade den 14 april att bolagets Zoom Uphill har färdigtestats enligt rullstol...
EcoRub publicerade den 14 april 2023 bolagets delårsrapport för det första kvartalet (Q1-23) och vis...
Rekryterar för att fortsätta utveckla erbjudandet och bibehålla tillväxttakten 2022 var ett händelse...
Bra tillväxt i Q1’23 med en svagare marginal y/y Waystream rapporterade en nettoomsättning på 30,4 m...
Redeye saw a sales performance in the quarter that did not meet our high expectations but still show...
On 12 April, Scanfil increased the midpoint of its 2023 revenue growth guidance range by 6%.
Redeye endorses the announcement that CLS and the US National Institutes of Health Clinical Center h...
Scandinavian Astor Group meddelade den 12 april att dotterbolaget Marstrom Composite AB har erhållit...
Q1 due 4 May; trends continue to look positive... .
Redeye sees a Q1 report that did not meet our high expectations.
Q1e: We expect SEK 35.5m revenue and 11.4m EBIT '23e-'25e sales reduced by 3-7% on lowered FX and cu...
Redeye provides a research update following the Q2 report published by Newbury yesterday.
